Associations of renin–angiotensin system inhibitor use with brain insulin signaling and neuropathology
Sign Up to like & getrecommendations! Published in 2024 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.52132
Abstract: To examine the associations of renin–angiotensin system (RAS) inhibitor use with postmortem brain insulin signaling and neuropathology. read more here.
Keywords: angiotensin system; associations renin; renin angiotensin; insulin signaling ... See more keywords
Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5112
Abstract: To assess the prevalence and potential indications of PDE5 inhibitor use among pregnant and reproductive‐age women in the United States. read more here.
Keywords: inhibitor use; pregnant reproductive; among pregnant; reproductive age ... See more keywords
Association Between Proton Pump Inhibitor Use and Alzheimer's Disease in Older Adults
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Geriatrics Society"
DOI: 10.1111/jgs.15474
Abstract: Conflict of Interest: None of the authors have conflicts of interest to disclose. Author Contributions: Aaron Pickens was the lead researcher and manuscript author. Andrew Namen was the principle investigator and generated the initial concept… read more here.
Keywords: inhibitor use; pump inhibitor; use alzheimer; alzheimer disease ... See more keywords
Examination of PD-1/PD-L1 inhibitor use and adverse events in a real-world setting.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e19294
Abstract: e19294 Background: Immune checkpoint blockade through PD-1 and PD-L1 inhibition is an effective treatment for multiple cancers. This study used administrative claims to examine potential adverse events (AEs) associated with real-world PD-1 or PD-L1 inhibitor… read more here.
Keywords: inhibitor use; real world; inhibitor; adverse events ... See more keywords
Pituitary Complications of Checkpoint Inhibitor Use.
Sign Up to like & getrecommendations! Published in 2024 at "Endocrinology"
DOI: 10.1210/endocr/bqae084
Abstract: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events (irAEs), including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered… read more here.
Keywords: epidemiology; pituitary complications; use; checkpoint inhibitor ... See more keywords
Association Between Prosthetic Knee Effusions and Phosphodiesterase Type-5 Enzyme Inhibitor Use After Total Knee Arthroplasty
Sign Up to like & getrecommendations! Published in 2023 at "JBJS Case Connector"
DOI: 10.2106/jbjs.cc.22.00622
Abstract: Case: Phosphodiesterase type-5 enzyme (PDE5) inhibitors are well tolerated and used to treat erectile dysfunction. We report a case of prosthetic knee effusions associated with PDE5 inhibitor use in a 65-year-old man after total knee… read more here.
Keywords: inhibitor use; inhibitor; phosphodiesterase type; knee ... See more keywords
Current status of selective nonsteroidal anti-inflammatory drug-COX-2 inhibitor use in outpatients with low back pain and cardiovascular comorbidities: An Analysis of the NAMCS Database.
Sign Up to like & getrecommendations! Published in 2025 at "JPMA. The Journal of the Pakistan Medical Association"
DOI: 10.47391/jpma.20611
Abstract: Objectives To analyse prescribing patterns of cyclooxygenase-2 inhibitor for low-back pain patients with cardiovascular comorbidities in American outpatient settings. METHODS The data of this retrospective, cross-sectional study were from the 2007-2019 National Ambulatory Medical Care… read more here.
Keywords: low back; cardiovascular comorbidities; inhibitor; cyclooxygenase inhibitor ... See more keywords
Inverse association between DPP-4 inhibitor use and fracture in older adults: A disproportionality analysis of the FAERS and JADER.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp204266
Abstract: OBJECTIVE Fractures are significantly associated with increased morbidity and mortality in older individuals; additionally, patients with diabetes mellitus are highly prone to fractures. The aim of the present study was to examine the association between… read more here.
Keywords: dpp inhibitor; fracture; inhibitor use; ror ... See more keywords